Mirjam de Waal
Papers
1
Total Citations
8
H-Index
1
About
Dr. Mirjam de Waal is a leading researcher in transfusion medicine and blood safety, with a focused expertise in emerging infectious disease surveillance. Her work is pivotal in assessing and mitigating risks to blood supplies, particularly through large-scale seroprevalence studies. Her most cited paper, "No evidence of West Nile virus infection in Dutch blood donors" (2006), is a landmark study that systematically evaluated the threat of West Nile virus (WNV) to the Dutch blood supply. By testing thousands of donor samples, Dr. de Waal provided critical evidence that WNV had not yet entered the Dutch donor population, directly informing national blood safety policies and reassuring public health authorities. This work, which has garnered 8 citations, exemplifies her rigorous, evidence-based approach to transfusion-transmitted infection risk assessment. Dr. de Waal’s contributions are essential for maintaining the safety of blood products, and her research continues to guide surveillance strategies for emerging pathogens in the Netherlands.
Research Focus
Key Achievements
Top Papers
- 1No evidence of West Nile virus infection in Dutch blood donors8 citations · 2006